DVA DaVita Inc. Common Stock

NYSE · Health Care · 在 SEC EDGAR 上查看 ↗
$177.22
价格 · 八月 20, 2026
截至...的财报数据 八月 4, 2026

关于 DaVita Inc. Common Stock 公司概况(来自维基百科)

DaVita Inc. is an American health care company, incorporated in Delaware and headquartered in Denver, that provides kidney dialysis services through a network of 2,657 outpatient centers in the United States. DaVita serves 200,500 patients, and has 585 outpatient centers in 14 other countries serving 94,500 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation.

阅读更多

DaVita Inc. (a shortened contraction of "dare vita, meaning "to give life" in the Italian language) is an American health care company, incorporated in Delaware and headquartered in Denver, that provides kidney dialysis services through a network of 2,657 outpatient centers in the United States. DaVita serves 200,500 patients (36% of the total of 557,000 patients in the U.S.), and has 585 outpatient centers in 14 other countries serving 94,500 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation.

In 2025, 68% of the company's revenues came from Medicare and other government-based health insurance programs. In 2025, 89% of the company's patients were covered by government-based health insurance programs. Commercial payers, which accounted for 32% of revenues in 2025, generate nearly all of the company's profit as they reimburse at a much higher rate than government-based health insurance programs. The company is ranked 331st on the 2026 Fortune 500.

History

The company was founded in 1979 as Medical Ambulatory Care, Inc., a subsidiary of National Medical Enterprises, Inc. (now Tenet Healthcare).

In August 1994, 70% of the company was acquired by DLJ Merchant Banking Partners in a leveraged buyout for $75.5 million, including a $10.5 million investment by DLJ. The company then changed its name to Total Renal Care Holdings, Inc. In October 1995, the company became a public company via an initial public offering, raising $107 million. By December 1996, DLJ had made a 386% return on its $10.5 million investment.

Acquisitions and divestments

On February 27, 1998, the company acquired Renal Treatment Centers for $1.3 billion in stock. The integration went poorly and in July 1999, the CEO and CFO resigned. After tripling in value between 1995 and 1998, by July 1999, the stock price was down 71% year-to-date. In October 1999, Kent J. Thiry, then 43 years old, was named CEO.

In 2000, the company sold its non-U.S. operations. In October 2000, the company was renamed DaVita Inc. In October 2005, the company acquired Gambro Healthcare. In 2012, DaVita acquired Healthcare Partners for $4.42 billion, which was renamed DaVita Medical Group. In June 2019, the division was sold to UnitedHealth Group for $4.3 billion. In 2014, DaVita acquired Colorado Springs Health Partners, with 600 employees and 110,000 patients. In March 2016, it acquired the Everett Clinic Medical Group, a 20-site physicians practice with 315,000 patients in the Seattle area, for $385 million. In May 2017, it acquired WellHealth Quality Care.

Legal issues

In October 2014, the company agreed to pay $350 million to settle claims that it provided illegal kickbacks to doctors. In June 2015, the company agreed to pay $450 million to settle allegations that it unnecessarily disposed of drugs and then billed the U.S. federal government for this waste. In June 2018, a jury awarded the families of 3 of the company's patients $383 million in wrongful death claims after the patients died from cardiac arrest after undergoing treatment at DaVita centers. In October 2018, it agreed to pay $270 million to settle allegations that it violated the False Claims Act by providing inaccurate information that caused Medicare Advantage Plans to receive inflated payments. James Swoben, a whistleblower, received $10 million.

In July 2021, a federal grand jury indicted DaVita and former CEO Kent Thiry on charges of labor market collusion alleging participation in conspiracies with Surgical Care Affiliates to suppress competition for the services of certain senior-level employees. The company and Thiry were acquitted by a jury in April 2022. In October 2021, the Federal Trade Commission imposed limits on the company engaging in more mergers in Utah because of its history of buying up competitors.

In 2024, the Federal Trade Commission began investigating Davita along with Fresenius Medical Care under allegations they use illegal tactics to push smaller companies out of the market. In May 2025, the benefits fund of the United Food and Commercial Workers Local 1776 filed a proposed class-action lawsuit against DaVita and Fresenius Medical Care, a rival dialysis provider, alleging that the two companies illegally conspired to inflate treatment costs.

来源:维基百科 (英语), CC BY-SA 4.0 · 在维基百科上查看 ↗

Wikidata ↗

DVA 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围

价格
$177.22
市值
$12.26B
P/E (TTM)
18.2
每股收益 (TTM)
$9.84
营收 (TTM)
$13.64B
股息收益率
0.00%
ROE
-281.8%
负债/权益
52周区间
$101 – $247

DVA 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图

10年表现 收入、净利润、利润率和每股收益趋势

营收与净利润 $13.64B
10-point trend, +27.4%
2016-12-31 2025-12-31
EPS $9.84
10-point trend, +129.4%
2016-12-31 2025-12-31
自由现金流 $1.31B
10-point trend, +15.5%
2016-12-31 2025-12-31
利润率 5.5%

估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜?

指标
5年趋势
DVA
同行中位数
P/E (TTM)
5-point trend, -9.7%
18.2
32.6
P/S (TTM) (市销率 (TTM))
5-point trend, -40.1%
0.9
2.0
P/B (市净率)
5-point trend, -181.7%
-18.8
4.4
Price / FCF (股价/自由现金流)
5-point trend, -30.8%
9.4

盈利能力 毛利率、营业利润率和净利率;股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)

指标
5年趋势
DVA
同行中位数
Operating Margin (营业利润率)
5-point trend, -3.2%
15.0%
Net Profit Margin (净利润率)
5-point trend, -35.0%
5.5%
2.4%
ROA
5-point trend, -25.1%
4.3%
4.5%
ROE
5-point trend, -408.1%
-281.8%
10.9%
ROIC
5-point trend, -229.3%
-245.6%

财务健康 债务、流动性、偿付能力 — 资产负债表强度

指标
5年趋势
DVA
同行中位数
Current Ratio (流动比率)
5-point trend, -2.2%
1.3
1.7
Quick Ratio (速动比率)
5-point trend, -2.6%
1.0

成长 营收、每股收益 (EPS) 和净利润增长:同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)

指标
5年趋势
DVA
同行中位数
Revenue YoY (营收同比增长)
5-point trend, +17.4%
6.5%
Revenue CAGR 3Y (营收3年复合年增长率)
5-point trend, +17.4%
5.5%
Revenue CAGR 5Y (营收5年复合年增长率)
5-point trend, +17.4%
3.4%
EPS YoY
5-point trend, +10.6%
-8.3%
Net Income YoY (净利润同比增长)
5-point trend, -23.7%
-20.2%

每股指标 每股收益 (EPS)、每股净资产、每股现金流、每股股息

指标
5年趋势
DVA
同行中位数
EPS (Diluted) (EPS (稀释))
5-point trend, +10.6%
$9.84

资本效率 资产周转率、库存周转率、应收账款周转率

指标
5年趋势
DVA
同行中位数
Payout Ratio (派息率)
Flat — no change across 5 periods
0.00%

股息 收益率、派息率、股息历史、5年CAGR

股息收益率
0.00%
派息率
0.00%
5年股息复合年增长率 (CAGR)

DVA 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间

持有 13 位分析师
  • 强烈买入 1 7.7%
  • 买入 5 38.5%
  • 持有 6 46.2%
  • 卖出 1 7.7%
  • 强烈卖出 0 0.0%

12个月价格目标

7 位分析师 · 2026-08-16
中位数目标 $220.00 +24.1%
平均目标 $218.43 +23.3%

收益历史 每股收益实际值 vs 预估值,惊喜%,达标率,下次财报日期

平均惊喜
-0.04%
期间 EPS Actual EPS 预期 惊喜
2026年6月30日 $4.02 $3.92 0.10%
2026年3月31日 $2.87 $2.34 0.53%
2025年12月31日 $3.40 $3.19 0.21%
2025年9月30日 $2.04 $3.25 -1.2%
2025年6月30日 $2.95 $2.83 0.12%
2025年3月31日 $2.00 $1.97 0.03%

同行比较(GICS 子行业) 关键指标与行业同行对比

股票代码 市值 P/E 营收同比增长 净利润率 ROE 毛利率
DVA $7.79B 11.5 6.5% 5.5% -281.8%
LH $20.62B 24.0 7.2% 6.3% 10.3% 28.8%
DGX $19.09B 19.8 11.8% 9.0% 14.2%
GH $13.34B -30.8 32.9% -42.4% 205.7%
LH $20.62B 24.0 7.2% 6.3% 10.3% 28.8%
BTSG $7.20B 43.0 28.2% 1.5% 10.8% 11.8%
HNGE $0 -6.0 50.6% -89.9% -299.8% 79.7%
CHE 23.3 4.1% 10.5% 24.4%
HIMS 63.7 59.0% 5.5% 23.3% 73.8%
RDNT $5.28B -285.4 11.5% -0.91% -1.9%
CVS $100.87B 57.1 7.8% 0.44% 2.4%

完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表

损益表 13
DVA 的年度损益表数据
指标 趋势 2025202420232022202120202019201820172016
Revenue 10-point trend, +27.4% $13.64B $12.82B $12.14B $11.61B $11.62B $11.55B $11.39B $11.40B $10.88B $10.71B
SG&A Expense 10-point trend, +56.0% $1.67B $1.54B $1.47B $1.36B $1.20B $1.25B $1.10B $1.14B $1.06B $1.07B
Operating Expenses 10-point trend, +33.7% $11.60B $10.73B $10.54B $10.27B $9.82B $9.86B $9.75B $9.88B $9.06B $8.68B
Operating Income 10-point trend, +0.7% $2.04B $2.09B $1.60B $1.34B $1.80B $1.69B $1.64B $1.53B $1.81B $2.03B
Other Non-op 10-point trend, -1467.2% $-103M $-70M $-19M $-16M $6M $17M $29M $10M $18M $8M
Pretax Income 10-point trend, -17.0% $1.35B $1.53B $1.18B $966M $1.52B $1.32B $1.20B $1.05B $1.40B $1.62B
Income Tax 10-point trend, -32.1% $293M $280M $220M $198M $307M $314M $280M $258M $324M $432M
Net Income 10-point trend, -15.1% $747M $936M $692M $560M $978M $774M $811M $159M $664M $880M
EPS (Basic) 10-point trend, +130.7% $10.06 $11.02 $7.62 $6.03 $9.30 $6.46 $5.29 $0.93 $3.52 $4.36
EPS (Diluted) 10-point trend, +129.4% $9.84 $10.73 $7.42 $5.85 $8.90 $6.31 $5.27 $0.92 $3.47 $4.29
Shares (Basic) 10-point trend, -63.2% 74,227,000 84,991,000 90,790,000 92,992,000 105,230,000 119,797,000 153,181,000 170,786,000 188,625,559 201,641,173
Shares (Diluted) 10-point trend, -63.0% 75,885,000 87,274,000 93,182,000 95,834,000 109,948,000 122,623,000 153,812,000 172,365,000 191,348,533 204,904,656
EBITDA 10-point trend, +12.8% $2.75B $2.81B $2.34B $2.06B $2.47B $2.31B $2.24B $2.10B $2.36B $2.44B
资产负债表 27
DVA 的年度资产负债表数据
指标 趋势 2025202420232022202120202019201820172016
Cash & Equivalents 10-point trend, +0.2% $676M $795M $380M $244M $462M $325M $1.10B $323M $508M $675M
Short-term Investments 10-point trend, -92.1% $24M $51M $12M $78M $22M $20M $12M $3M $33M $307M
Receivables 10-point trend, +60.6% $2.41B $2.15B $1.99B $2.13B $1.96B $1.82B $1.80B $1.86B $1.71B $1.50B
Inventory 10-point trend, +0.1% $161M $135M $143M $109M $107M $112M $98M $107M $182M $160M
Prepaid Expense 10-point trend, +57.1% $156M $123M $103M $79M $73M $76M $67M $112M $112M $100M
Other Current Assets 2-point trend, +12.6% · · · · · · · · $112M $100M
Current Assets 10-point trend, +1.6% $4.06B $3.75B $3.14B $3.16B $3.17B $3.15B $3.69B $8.42B $8.77B $3.99B
PP&E (Net) 10-point trend, -1.8% $2.81B $2.94B $3.07B $3.26B $3.48B $3.52B $3.47B $3.39B $3.15B $2.86B
PP&E (Gross) 10-point trend, +69.3% $9.42B $9.20B $8.83B $8.52B $8.24B $8.00B $7.44B $6.92B $6.25B $5.56B
Accum. Depreciation 10-point trend, +144.7% $6.60B $6.26B $5.76B $5.27B $4.76B $4.48B $3.97B $3.52B $3.10B $2.70B
Goodwill 10-point trend, +25.4% $7.55B $7.38B $7.11B $7.08B $7.05B $6.92B $6.79B $6.84B $6.61B $6.02B
Intangibles 10-point trend, +202.2% $222M $197M $203M $183M $178M $167M $136M $119M $114M $74M
Other Non-current Assets 10-point trend, +628.1% $247M $262M $271M $316M $137M $80M $116M $72M $47M $34M
Total Assets 10-point trend, -6.8% $17.48B $17.29B $16.89B $16.93B $17.12B $16.99B $17.31B $19.11B $18.97B $18.76B
Accounts Payable 10-point trend, +52.5% $696M $547M $515M $480M $402M $434M $404M $463M $509M $457M
Current Liabilities 10-point trend, +15.9% $3.14B $2.97B $2.64B $2.62B $2.40B $2.48B $2.37B $4.89B $3.07B $2.71B
Capital Leases 8-point trend, +2175658000.00 $2.18B $2.21B $2.33B $2.50B $2.67B $2.74B $2.72B $0 · ·
Deferred Tax 10-point trend, +42.6% $757M $665M $726M $783M $831M $810M $578M $563M $486M $531M
Other Non-current Liabilities 10-point trend, -73.7% $84M $170M $183M $105M $119M $150M $161M $451M $365M $317M
Total Liabilities 10-point trend, +26.2% $16.32B $15.19B $14.15B $14.70B $14.75B $14.09B $13.81B $14.08B $13.08B $12.93B
Common Stock 10-point trend, -64.6% $69.0K $90.0K $89.0K $90.0K $97.0K $110.0K $126.0K $166.0K $182.0K $195.0K
Retained Earnings 10-point trend, -108.9% $-328M $1.53B $598M $174M $354M $853M $1.43B $2.74B $3.63B $3.71B
Treasury Stock 9-point trend, +199940000.00 $200M $1.39B $0 · $0 $0 $0 $0 $0 $0
AOCI 10-point trend, -37.0% $-123M $-311M $-52M $-69M $-139M $-66M $-47M $-35M $13M $-90M
Stockholders' Equity 10-point trend, -114.0% $-651M $121M $1.06B $712M $756M $1.38B $2.13B $3.70B $4.69B $4.65B
Liabilities + Equity 10-point trend, -6.8% $17.48B $17.29B $16.89B $16.93B $17.12B $16.99B $17.31B $19.11B $18.97B $18.76B
Shares Outstanding 10-point trend, -64.8% 68,549,000 90,369,000 88,824,000 90,411,000 97,289,000 109,933,000 125,843,000 166,387,000 182,462,000 194,554,000
现金流 17
DVA 的年度现金流数据
指标 趋势 2025202420232022202120202019201820172016
D&A 10-point trend, +43.1% $708M $716M $736M $721M $668M $617M $601M $575M $544M $495M
Stock-based Comp 10-point trend, +265.1% $140M $103M $112M $95M $102M $91M $68M $73M $35M $38M
Deferred Tax 10-point trend, +66.5% $87M $-58M $-39M $-76M $60M $241M $42M $274M $-395M $52M
Amort. of Intangibles 10-point trend, -51.2% $7M $7M $9M $11M $13M $14M $14M $16M $16M $15M
Other Non-cash 10-point trend, -54.2% $205M $324M $558M $263M $122M $256M $551M $691M $1.06B $447M
Operating Cash Flow 10-point trend, -4.3% $1.89B $2.02B $2.06B $1.56B $1.93B $1.98B $2.07B $1.77B $1.91B $1.97B
CapEx 10-point trend, -30.5% $576M $555M $568M $603M $641M $675M $767M $987M $905M $829M
Investing Cash Flow 10-point trend, +45.5% $-655M $-771M $-772M $-630M $-785M $-825M $3.00B $-1.01B $-1.36B $-1.20B
Debt Issued 10-point trend, -89.2% $5.61B $6.62B $2.47B $2.39B $1.62B $4.05B $38.53B $59.93B $50.99B $51.99B
Net Debt Issued 10-point trend, -89.2% $5.61B $6.62B $2.47B $2.39B $1.62B $4.05B $38.53B $59.93B $50.99B $51.99B
Stock Repurchased 10-point trend, +19.2% $1.31B $1.39B $272M $802M $1.54B $1.46B $2.38B $1.16B $803M $1.10B
Net Stock Activity 10-point trend, -19.2% $-1.31B $-1.39B $-272M $-802M $-1.54B $-1.46B $-2.38B $-1.16B $-803M $-1.10B
Dividends Paid Flat — no change across 8 periods $0 $0 $0 $0 $0 $0 $0 $0 · ·
Financing Cash Flow 10-point trend, -1.7% $-1.37B $-817M $-1.17B $-1.12B $-1.08B $-1.85B $-4.70B $-625M $-766M $-1.35B
Net Change in Cash 10-point trend, +78.9% $-122M $415M $126M $-216M $53M $-707M $369M $137M $-218M $-577M
Taxes Paid 3-point trend, -34.1% $177M $388M $268M · · · · · · ·
Free Cash Flow 10-point trend, +15.5% $1.31B $1.47B $1.49B $961M $1.29B $1.30B $1.31B $785M $1.00B $1.13B
盈利能力 7
DVA 的年度盈利能力数据
指标 趋势 2025202420232022202120202019201820172016
Operating Margin 8-point trend, +12.0% 15.0% 16.3% 13.2% 11.5% 15.5% 14.7% 14.4% 13.4% · ·
Net Margin 8-point trend, +290.7% 5.5% 7.3% 5.7% 4.8% 8.4% 6.7% 7.1% 1.4% · ·
Pretax Margin 8-point trend, +7.4% 9.9% 11.9% 9.7% 8.3% 13.1% 11.4% 10.5% 9.2% · ·
EBITDA Margin 8-point trend, +9.5% 20.2% 21.9% 19.3% 17.8% 21.2% 20.0% 19.7% 18.4% · ·
ROA 10-point trend, -8.9% 4.3% 5.5% 4.1% 3.3% 5.7% 4.5% 4.5% 0.84% 3.5% 4.7%
ROE 10-point trend, -1624.2% -281.8% 159.1% 78.2% 76.4% 91.5% 44.0% 27.8% 3.8% 14.2% 18.5%
ROIC 10-point trend, -968.4% -245.6% 1410.5% 123.4% 149.4% 189.8% 93.3% 59.0% 31.1% 29.7% 28.3%
流动性与偿付能力 2
DVA 的年度流动性与偿付能力数据
指标 趋势 2025202420232022202120202019201820172016
Current Ratio 10-point trend, -12.5% 1.3 1.3 1.2 1.2 1.3 1.3 1.6 1.7 2.9 1.5
Quick Ratio 10-point trend, -14.9% 1.0 1.0 0.9 0.9 1.0 0.9 1.2 0.4 0.7 1.2
效率 2
DVA 的年度效率数据
指标 趋势 2025202420232022202120202019201820172016
Asset Turnover 8-point trend, +31.1% 0.8 0.7 0.7 0.7 0.7 0.7 0.6 0.6 · ·
Receivables Turnover 8-point trend, -6.3% 6.0 6.2 5.9 5.7 6.1 6.4 6.2 6.4 · ·
每股 5
DVA 的年度每股数据
指标 趋势 2025202420232022202120202019201820172016
Book Value / Share 10-point trend, -139.8% $-9.50 $1.50 $11.89 $7.88 $7.77 $12.59 $16.95 $22.26 $25.70 $23.89
Revenue / Share 8-point trend, +171.7% $179.79 $146.84 $130.28 $121.15 $105.68 $94.20 $74.04 $66.17 · ·
Cash Flow / Share 10-point trend, +159.4% $24.86 $23.17 $22.10 $16.33 $17.56 $16.14 $13.47 $10.28 $9.97 $9.58
Cash / Share 10-point trend, +110.2% $9.87 $9.87 $4.28 $2.70 $4.75 $2.96 $8.76 $1.94 $2.79 $4.69
EPS (TTM) 10-point trend, +129.4% $9.84 $10.73 $7.42 $5.85 $8.90 $6.31 $5.27 $0.92 $3.47 $4.29
增长率 9
DVA 的年度增长率数据
指标 趋势 2025202420232022202120202019201820172016
Revenue YoY 5-point trend, +994.9% 6.5% 5.6% 4.6% -0.08% 0.59% · · · · ·
Revenue CAGR 3Y 3-point trend, +231.1% 5.5% 3.3% 1.7% · · · · · · ·
Revenue CAGR 5Y 3.4% · · · · · · · · ·
EPS YoY 5-point trend, -120.2% -8.3% 44.6% 26.8% -34.3% 41.0% · · · · ·
EPS CAGR 3Y 3-point trend, +241.1% 18.9% 6.4% 5.5% · · · · · · ·
EPS CAGR 5Y 9.3% · · · · · · · · ·
Net Income YoY 5-point trend, -176.5% -20.2% 35.4% 23.4% -42.7% 26.5% · · · · ·
Net Income CAGR 3Y 3-point trend, +373.6% 10.0% -1.5% -3.7% · · · · · · ·
Net Income CAGR 5Y -0.70% · · · · · · · · ·
估值 (TTM) 12
DVA 的年度估值 (TTM)数据
指标 趋势 2025202420232022202120202019201820172016
Revenue TTM 10-point trend, +27.4% $13.64B $12.82B $12.14B $11.61B $11.62B $11.55B $11.39B $11.40B $10.88B $10.71B
Net Income TTM 10-point trend, -15.1% $747M $936M $692M $560M $978M $774M $811M $159M $664M $880M
Market Cap 10-point trend, -37.6% $7.79B $12.04B $9.31B $6.75B $11.07B $12.91B $9.44B $8.56B $13.18B $12.49B
P/E 10-point trend, -22.8% 11.5 13.9 14.1 12.8 12.8 18.6 14.2 55.9 20.8 15.0
P/S 10-point trend, -51.1% 0.6 0.9 0.8 0.6 1.0 1.1 0.8 0.8 1.2 1.2
P/B 10-point trend, -545.1% -12.0 99.4 8.8 9.5 14.6 9.3 4.4 2.3 2.8 2.7
P / Cash Flow 10-point trend, -35.1% 4.1 6.0 4.5 4.3 5.7 6.5 4.6 4.8 6.9 6.4
P / FCF 10-point trend, -46.0% 5.9 8.2 6.2 7.0 8.6 9.9 7.2 10.9 13.2 11.0
Dividend Yield Flat — no change across 8 periods 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% · ·
Earnings Yield 10-point trend, +29.6% 8.7% 7.2% 7.1% 7.8% 7.8% 5.4% 7.0% 1.8% 4.8% 6.7%
Payout Ratio Flat — no change across 7 periods 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% · · ·
Annual Payout Flat — no change across 8 periods $0 $0 $0 $0 $0 $0 $0 $0 · ·

财务报表 损益表、资产负债表、现金流量表 — 年度,近5年

损益表
2025-12-312024-12-312023-12-312022-12-312021-12-31
收入 $13.64B$12.82B$12.14B$11.61B$11.62B
营业利润率 % 15.0%16.3%13.2%11.5%15.5%
净收入 $747M$936M$692M$560M$978M
稀释后每股收益 (EPS) $9.84$10.73$7.42$5.85$8.90
资产负债表
2025-12-312024-12-312023-12-312022-12-312021-12-31
流动比率 1.31.31.21.21.3
速动比率 1.01.00.90.91.0
现金流
2025-12-312024-12-312023-12-312022-12-312021-12-31
自由现金流 $1.31B$1.47B$1.49B$961M$1.29B

交易信号 近期买入/卖出信号,包含入场价和风险/回报比

我的指标 您的个人关注列表 — 来自完整基本面的选定行

📊

选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。

您的选择已保存,并会跟随您浏览所有股票。

机构持有人 (13F) 699 家申报者 · $7.9B 总计 · 截至 2026年6月30日

在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸;单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存,而非方向性判断。

机构活动 — Q2 2026 与上一季度对比
新仓位 已退出持仓 增加 减少 净股数变动
132 (-6 与上一季度对比) 60 (-3 与上一季度对比) 184 (+11 与上一季度对比) 218 (+12 与上一季度对比) -251K

与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天,外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过,优先显示最近一个已完整报告的季度对。

机构 价值 股份 % 已追踪的13F 类型
Berkshire Hathaway Inc $3331328308 14973608 42.03% 股份
VANGUARD CAPITAL MANAGEMENT LLC $467525034 2101425 5.90% 股份
VANGUARD PORTFOLIO MANAGEMENT LLC $306558307 1377914 3.87% 股份
STATE STREET CORP $294345267 1323019 3.71% 股份
DIMENSIONAL FUND ADVISORS LP $235869514 1060183 2.98% 股份
NEUBERGER BERMAN GROUP LLC $199315922 896621 2.51% 股份
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $197802963 889082 2.50% 股份
GEODE CAPITAL MANAGEMENT, LLC $165824664 746907 2.09% 股份
SUSQUEHANNA INTERNATIONAL GROUP, LLP $163166832 733400 2.06% 买入期权
Gates Capital Management, Inc. $153096497 688136 1.93% 股份
BANK OF AMERICA CORP /DE/ $133302007 599164 1.68% 股份
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $81331791 365569 1.03% 股份
NORGES BANK $76627007 344422 0.97% 股份
NORDEA INVESTMENT MANAGEMENT AB $67404554 305067 0.85% 股份
GOLDMAN SACHS GROUP INC $63752756 286555 0.80% 股份
D. E. Shaw & Co., Inc. $62040995 278861 0.78% 股份
JANE STREET GROUP, LLC $53573184 240800 0.68% 买入期权
Holocene Advisors, LP $52875709 237665 0.67% 股份
SUSQUEHANNA INTERNATIONAL GROUP, LLP $48100176 216200 0.61% 卖出期权
Quantinno Capital Management LP $45366106 203910 0.57% 股份
CITADEL ADVISORS LLC $44465298 199862 0.56% 股份
CITADEL ADVISORS LLC $44184528 198600 0.56% 买入期权
VANGUARD FIDUCIARY TRUST CO $40134502 180396 0.51% 股份
WEDGE CAPITAL MANAGEMENT L L P/NC $37089700 241328 0.47% 股份
Gotham Asset Management, LLC $36393278 163580 0.46% 股份
JANE STREET GROUP, LLC $35774784 160800 0.45% 卖出期权
Doma Perpetual Capital Management LLC $35522937 159668 0.45% 股份
FIRST TRUST ADVISORS LP $34161205 153548 0.43% 股份
TODD ASSET MANAGEMENT LLC $32697663 146969 0.41% 股份
LOS ANGELES CAPITAL MANAGEMENT LLC $32011312 143884 0.40% 股份
Allianz Asset Management GmbH $30236367 135906 0.38% 股份
MORGAN STANLEY $28624054 128659 0.36% 股份
Toroso Investments, LLC $28283664 248954 0.36% 股份
CANADA PENSION PLAN INVESTMENT BOARD $26480460 119024 0.33% 股份
BlackRock, Inc. $26457544 118921 0.33% 股份
VICTORY CAPITAL MANAGEMENT INC $26377896 118563 0.33% 股份
Amundi $25967198 116717 0.33% 股份
BARCLAYS PLC $25933826 116567 0.33% 股份
Davidson Kempner Capital Management LP $25162043 113098 0.32% 股份
ENVESTNET ASSET MANAGEMENT INC $23582658 105999 0.30% 股份
VANGUARD GROUP INC $23117136 203478 0.29% 股份
RHUMBLINE ADVISERS $23076629 103725 0.29% 股份
Woodline Partners LP $22872501 102807 0.29% 股份
UBS Group AG $20846376 93700 0.26% 卖出期权
MILLENNIUM MANAGEMENT LLC $20579400 92500 0.26% 卖出期权
FMR LLC $20183608 90721 0.25% 股份
SCHRODER INVESTMENT MANAGEMENT GROUP $19532854 87796 0.25% 股份
MILLENNIUM MANAGEMENT LLC $17151873 77094 0.22% 股份
California Public Employees Retirement System $15370253 69086 0.19% 股份
Swiss National Bank $14906160 67000 0.19% 股份
Vanguard Global Advisers, LLC $14696806 66059 0.19% 股份
WOLVERINE TRADING, LLC $14482431 110900 0.18% 卖出期权
National Philanthropic Trust $14000889 62931 0.18% 股份
PineBridge Investments, L.P. $13874153 104419 0.18% 股份
TUDOR INVESTMENT CORP ET AL $13325440 59895 0.17% 股份
BNP PARIBAS FINANCIAL MARKETS $13022644 58534 0.16% 股份
Candriam S.C.A. $12727615 57263 0.16% 股份
DANSKE BANK A/S $12471116 56055 0.16% 股份
CITADEL ADVISORS LLC $12280896 55200 0.15% 卖出期权
Susquehanna Portfolio Strategies, LLC $12219714 54925 0.15% 股份
MILLENNIUM MANAGEMENT LLC $11902680 53500 0.15% 买入期权
STOREBRAND ASSET MANAGEMENT AS $11500659 51693 0.15% 股份
LPL Financial LLC $10778934 48449 0.14% 股份
Robeco Institutional Asset Management B.V. $10083684 45324 0.13% 股份
Callahan Advisors, LLC $10033403 45098 0.13% 股份
Assenagon Asset Management S.A. $9963322 44783 0.13% 股份
Verition Fund Management LLC $9740174 43780 0.12% 股份
Prospera Financial Services Inc $9482479 42623 0.12% 股份
Te Ahumairangi Investment Management Ltd $9480318 42612 0.12% 股份
SEI INVESTMENTS CO $9251830 41585 0.12% 股份
Connor, Clark & Lunn Investment Management Ltd. $9207557 41386 0.12% 股份
Inlet Private Wealth, LLC $9004878 40475 0.11% 股份
Mitsubishi UFJ Asset Management Co., Ltd. $8835126 39712 0.11% 股份
Caisse de depot et placement du Quebec $8721216 39200 0.11% 股份
Twin Tree Management, LP $8454240 38000 0.11% 买入期权
Brevan Howard Capital Management LP $8343000 37500 0.11% 买入期权
CITIGROUP INC $8298504 37300 0.10% 卖出期权
NISA INVESTMENT ADVISORS, LLC $7947431 35722 0.10% 股份
IEQ CAPITAL, LLC $7900154 35510 0.10% 股份
UBS Group AG $7386336 33200 0.09% 买入期权
Counterpoint Mutual Funds LLC $7384111 33190 0.09% 股份
VANGUARD ASSET MANAGEMENT, Ltd $7170308 32229 0.09% 股份
FIFTH THIRD BANCORP $7074159 31797 0.09% 股份
Summit Trail Advisors, LLC $7043272 31658 0.09% 股份
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM $6953397 45243 0.09% 股份
Corient Private Wealth LP $6916838 31117 0.09% 股份
Tredje AP-fonden $6780968 30479 0.09% 股份
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM $6656824 29921 0.08% 股份
MANUFACTURERS LIFE INSURANCE COMPANY, THE $6539132 29392 0.08% 股份
SUSQUEHANNA INTERNATIONAL GROUP, LLP $6407202 28799 0.08% 股份
NATIONAL BANK OF CANADA /FI/ $6204782 27888 0.08% 股份
Walleye Capital LLC $6184944 27800 0.08% 买入期权
GHP Investment Advisors, Inc. $6107487 39739 0.08% 股份
Wakefield Asset Management LLLP $5893051 26488 0.07% 股份
STATE OF WISCONSIN INVESTMENT BOARD $5749551 25843 0.07% 股份
ALLIANCEBERNSTEIN L.P. $5566805 36221 0.07% 股份
NEW YORK STATE COMMON RETIREMENT FUND $5507937 24757 0.07% 股份
CWA Asset Management Group, LLC $5003575 22490 0.06% 股份
Legal & General Group Plc $4992452 22440 0.06% 股份
Mitsubishi UFJ Trust & Banking Corp $4942393 22215 0.06% 股份

公司内部人士 59 位内幕人士 · 31 位高管 · 25 位董事

内部人士 角色 上次活动 持股数量 买入 12个月 卖出 12个月 净额 12个月
Javier Rodriguez Chief Executive Officer 2026年6月16日 S 840408 0 2 $-14532097
Dennis Kogod Pres, HCP & CEO, DVA Int. 2016年5月17日 S 18766 0 0 $0
Joel Ackerman CFO and Treasurer 2026年5月7日 S 132434 0 1 $-9887579
Luis Borgen Chief Financial Officer 2012年3月22日 M 18517 0 0 $0
Richard K Whitney Chief Financial Officer 2010年3月31日 A 33604 0 0 $0
Mark G Harrison Chief Financial Officer 2007年3月14日 A 31250 0 0 $0
Gary Beil Acting Chief Financial Officer 2006年7月1日 A 10000 0 0 $0
David Paul Maughan Chief Operating Officer, DKC 2026年5月12日 S 94105 0 2 $-4089696
Michael David Staffieri Chief Operating Officer, DKC 2024年8月16日 S 209365 0 0 $0
Joseph C Mello COO, HCP 2016年12月24日 A 4688 0 0 $0
Kathleen Alyce Waters Chief Legal & Pub. Affairs Off 2026年6月15日 S 109194 0 2 $-3210360
James O Hearty Chief Compliance Officer 2026年5月14日 M 22389 0 2 $-3291616
Christopher Michael Berry Chief Accounting Officer 2026年3月15日 A 19640 0 0 $0
John D Winstel Chief Accounting Officer 2023年3月15日 F 15676 0 0 $0
Leanne M Zumwalt Group VP, Government Affairs 2020年9月18日 M 24590 0 0 $0
Kent J Thiry Executive Chairman 2020年6月1日 F 110462 0 0 $0
James K Hilger Chief Accounting Officer 2019年6月2日 F 33125 0 0 $0
Jeanine Marie Jiganti Chief Compliance Officer 2017年6月13日 M 3514 0 0 $0
Kim M Rivera Chief Legal Officer 2015年9月22日 M 7438 0 0 $0
Robert J Margolis Co-Chairman of the Board 2015年6月4日 S 2322928 0 0 $0
Allen Nissenson Chief Medical Officer 2014年2月13日 M 8990 0 0 $0
Garry E Menzel Senior Vice President, Finance 2013年9月9日 A 0 0 $0
David T Shapiro Chief Special Counsel 2013年8月2日 G 2315 0 0 $0
Thomas O Usilton Senior Vice President 2012年2月29日 M 17491 0 0 $0
Georgina Randolph Senior Vice President 2009年6月17日 M 5547 0 0 $0
Joseph Schohl VP, Gen. Counsel & Secretary 2009年2月13日 M 2084 0 0 $0
Christopher J Riopelle Chief Compliance Officer 2008年8月11日 M 2500 0 0 $0
Mary Kowenhoven Vice President - Strategy 2008年3月5日 A 0 0 $0
Patricia Jones Chief People Officer 2007年7月16日 A 6250 0 0 $0
Charles J Mcallister Chief Medical Officer 2007年5月8日 M 999 0 0 $0
Thomas L Kelly Executive Vice President 2005年11月4日 M 42000 0 0 $0
Dennis W Pullin 董事 2026年8月15日 A 2949 0 0 $0
Gregory J. Moore 董事 2026年8月15日 A 8091 0 0 $0
Jason M. Hollar 董事 2026年8月15日 A 6883 0 0 $0
Patricia M Arway 董事 2026年8月15日 A 27223 0 0 $0
Adam H Schechter 董事 2026年8月15日 A 5970 0 0 $0
Wendy Lee Schoppert 董事 2026年8月15日 A 278 0 0 $0
Phyllis R Yale 董事 2026年8月15日 A 9803 0 0 $0
Barbara J Desoer 董事 2026年8月15日 A 278 0 0 $0
Charles Berg 董事 2025年5月15日 A 19982 0 0 $0
John M Nehra 董事 2024年5月15日 A 363 0 0 $0
Paul J Diaz 董事 2023年5月15日 A 16069 0 0 $0
Paula A Price 董事 2022年5月15日 A 1395 0 0 $0
Shawn M Guertin 董事 2021年5月15日 A 1105 0 0 $0
Pascal Desroches 董事 2020年11月15日 A 8030 0 0 $0
William L Roper 董事 2020年6月11日 A 16234 0 0 $0
Peter T Grauer 董事 2020年6月11日 A 76204 0 0 $0
Carol Anthony Davidson 董事 2017年12月31日 A 10764 0 0 $0
Willard Woodson Brittain JR 董事 2012年6月11日 A 7195 0 0 $0
Richard C Vaughan 董事 2010年5月13日 A 6092 0 0 $0

来自SEC表格3/4/5申报的内部人士;净额=仅公开市场买卖

激进投资者及 5%+ 股东 1 持仓

提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权,意图影响发行人(激进股东持股、董事会活动、并购)。每一行显示该申报人持仓的最新已知状态。

申报人 已申报 持股 状态 目的 申报
Warren E. Buffett, Berkshire Hathaway Inc., National Indemnity Company, GEICO Corporation, Government Employees Insurance Company, Berkshire Hathaway Consolidated Pension Plan Master Trust, BNSF Master Retirement Trust, Scott Fetzer Company Collective Investment Trust, R. Ted Weschler ×13 申报 2025年2月13日 45.00% 修订 SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

ETF持仓 由 129 只交易所交易基金持有

权重仅反映直接股权持仓(N-PORT);杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。

基金 权重 单位 截至 来源
OMAH · Tidal Trust III 4.50% 217039 NS 2026年4月30日 N-PORT
AZTD · Tidal Trust I 2.74% 7761 NS 2026年4月30日 N-PORT
FXH · First Trust Exchange-Traded Alpha... 2.19% 123121 NS 2026年4月30日 N-PORT
AGNG · Global X Funds 0.92% 3855 NS 2026年5月31日 N-PORT
PY · Principal Exchange-Traded Funds 0.85% 8414 NS 2026年6月30日 N-PORT
LSEQ · Harbor ETF Trust 0.76% 758 NS 2026年4月30日 N-PORT
SIXL · EXCHANGE TRADED CONCEPTS TRUST 0.56% 5441 NS 2026年5月31日 N-PORT
ITAN · EA Series Trust 0.38% 1735 NS 2026年5月29日 N-PORT
JPME · J.P. Morgan Exchange-Traded Fund ... 0.38% 10626 NS 2026年4月30日 N-PORT
AFLG · First Trust Exchange-Traded Fund ... 0.34% 11220 NS 2026年5月31日 N-PORT
AFMC · First Trust Exchange-Traded Fund ... 0.30% 2502 NS 2026年5月31日 N-PORT
JMID · Janus Detroit Street Trust 0.30% 352 NS 2026年4月30日 N-PORT
IQSM · New York Life Investments ETF Trust 0.23% 4682 NS 2026年4月30日 N-PORT
ROSC · Lattice Strategies Trust 0.18% 635 NS 2026年4月30日 N-PORT
BKMC · BNY Mellon ETF Trust 0.14% 5728 NS 2026年4月30日 N-PORT
FNK · First Trust Exchange-Traded Alpha... 0.14% 1975 NS 2026年4月30日 N-PORT
DFAS · Dimensional ETF Trust 0.14% 124181 NS 2026年4月30日 N-PORT
JPUS · J.P. Morgan Exchange-Traded Fund ... 0.13% 3564 NS 2026年4月30日 N-PORT
SCHM · SCHWAB STRATEGIC TRUST 0.12% 90512 NS 2026年5月31日 N-PORT
BBMC · J.P. Morgan Exchange-Traded Fund ... 0.11% 14233 NS 2026年4月30日 N-PORT
FHLC · FIDELITY COVINGTON TRUST 0.10% 17983 NS 2026年4月30日 N-PORT
RXL · ProShares Trust 0.09% 348 NS 2026年5月31日 N-PORT
CURE · Direxion Shares ETF Trust 0.07% 667 NS 2026年4月30日 N-PORT
FNX · First Trust Exchange-Traded Alpha... 0.07% 5907 NS 2026年4月30日 N-PORT
AVMC · AMERICAN CENTURY ETF TRUST 0.07% 1423 NS 2026年5月31日 N-PORT
DEUS · DBX ETF Trust 0.07% 930 NS 2026年5月29日 N-PORT
TILT · FlexShares Trust 0.05% 6930 NS 2026年4月30日 N-PORT
DUHP · Dimensional ETF Trust 0.04% 32462 NS 2026年4月30日 N-PORT
FAB · First Trust Exchange-Traded Alpha... 0.04% 381 NS 2026年4月30日 N-PORT
DFAC · Dimensional ETF Trust 0.04% 122200 NS 2026年4月30日 N-PORT
FNDX · SCHWAB STRATEGIC TRUST 0.04% 55529 NS 2026年5月31日 N-PORT
FNDB · SCHWAB STRATEGIC TRUST 0.04% 2663 NS 2026年5月31日 N-PORT
MSSM · MORGAN STANLEY PATHWAY FUNDS 0.04% 1481 NS 2026年5月31日 N-PORT
SPXD · DBX ETF Trust 0.04% 13 NS 2026年5月31日 N-PORT
DCOR · Dimensional ETF Trust 0.03% 5268 NS 2026年4月30日 N-PORT
GGUS · Goldman Sachs ETF Trust 0.03% 625 NS 2026年5月31日 N-PORT
CATH · Global X Funds 0.02% 1873 NS 2026年4月30日 N-PORT
SCHV · SCHWAB STRATEGIC TRUST 0.02% 17221 NS 2026年5月31日 N-PORT
SFGV · EA Series Trust 0.02% 1316 NS 2026年5月29日 N-PORT
SNPE · DBX ETF Trust 0.02% 2769 NS 2026年5月29日 N-PORT
DFAU · Dimensional ETF Trust 0.02% 13138 NS 2026年4月30日 N-PORT
SPXT · ProShares Trust 0.02% 224 NS 2026年5月31日 N-PORT
DFSU · Dimensional ETF Trust 0.02% 2080 NS 2026年4月30日 N-PORT
EGLE · Global X Funds 0.02% 2 NS 2026年4月30日 N-PORT
CHRI · Global X Funds 0.02% 5 NS 2026年4月30日 N-PORT
AVSU · AMERICAN CENTURY ETF TRUST 0.01% 348 NS 2026年5月31日 N-PORT
SPXN · ProShares Trust 0.01% 47 NS 2026年5月31日 N-PORT
JUST · Goldman Sachs ETF Trust 0.01% 326 NS 2026年5月31日 N-PORT
SPXE · ProShares Trust 0.01% 46 NS 2026年5月31日 N-PORT
GUSA · Goldman Sachs ETF Trust II 0.01% 1198 NS 2026年5月31日 N-PORT